Healthcare services and CRO concept stocks continued to weaken, and Aoyang Health hit a standstill, and Novo Zhiyuan, Baihua Pharmaceuticals, Wanbang Pharmaceuticals, Gloria Ying, and Nanmo Biotech followed suit.

Zhitongcaijing · 4d ago
Healthcare services and CRO concept stocks continued to weaken, and Aoyang Health hit a standstill, and Novo Zhiyuan, Baihua Pharmaceuticals, Wanbang Pharmaceuticals, Gloria Ying, and Nanmo Biotech followed suit.